19092-Solid Tumors-NA-1066

Solid Tumors

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number:

  • Address

3144 Horizon Rd, Suite 110
Rockwall, TX 75032
P: (972) 771-3322

Search by practice name, trial titles, indicators and specific disease types.